CSL LtdEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 127.93 AUD | 266,869 AUD | 90 AUD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - AUD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 478.911.979 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name CSL Ltd
Mitarbeiter 29.904
Handelsplatz AU
Ticker Symbol CSL
IPO Datum -
Adresse 655 Elizabeth Street, Melbourne, VIC, Australia, 3000
Webseite https://www.csl.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Gordon Naylor BEng (Hons), C.P.A., DipCompSc, M.B.A. | CEO, MD & Director |
| 2 | Mr. Ken Lim | Chief Financial Officer |
| 3 | Dr. Mary Oates Ph.D. | Executive VP & COO |
| 4 | Mr. Mark Dehring | Head of Investor Relations |
| 5 | Mr. Gregory Boss B.S., BS(Hons), J.D. | Executive VP of Legal & Group General Counsel |
| 6 | Ms. Amy Van Buren | Chief People Officer |
| 7 | Dr. William Mezzanotte M.D., M.P.H. | Chief Medical Officer, Executive VP and Head of Research & Development |
| 8 | Mr. Stephen Marlow | Executive VP & GM of CSL Plasma |
| 9 | Mr. Mark Hill B.A., M.B.A. | Chief Digital Information Officer & Executive VP |
| 10 | Ms. Deirdre BeVard | Senior Vice President of Research & Development Strategic Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.